Form 8-K · Current Report · Filed 2024-09-05
McKesson Announces Fiscal 2025 Earnings Guidance
On September 5, 2024, McKesson Corporation affirmed its fiscal 2025 full-year Adjusted Earnings per Diluted Share guidance in the range of $31.75 to $32.55, and indicated second quarter Adjusted earnings per Diluted Share to be in the range of $6.70 to $7.00.
- Filer
- McKesson Corporation MCK · NYSE
- Filed
- Accession
- 0000927653-24-000106
- CIK
- 0000927653
- Signal
- Low impactHealthcare
- Source
- Official filing on sec.gov ↗
Details
This disclosure was made during the Wells Fargo 2024 Healthcare Conference as previously noticed in the company's August 7, 2024 earnings release.
Items reported
Regulation FD Disclosure
Market reaction
Close before filing
$571.28
Next session
-11.7%
Since filing
+49.9%
Latest close
$856.19
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from MCK reporting the same item, with the next session's move:
About McKesson Corporation
McKesson Corporation is a leading healthcare services and information technology company. It plays a crucial role in the distribution of pharmaceuticals and medical products. The primary function of McKesson is to ensure the efficient delivery of healthcare products to pharmacies, hospitals, and other medical facilities, ensuring that millions of patients have access to the medications they need. It also provides specialized software and automated solutions that enhance operational efficiency in healthcare sectors. McKesson significantly impacts the pharmaceutical and healthcare industries by offering solutions that streamline supply chains and improve patient care. Its services encompass wholesale drug distribution, healthcare IT systems, and pharmacy management. With operations that extend globally, McKesson is integral to maintaining the integrity and reliability of healthcare supply networks. By handling a substantial portion of the pharmaceutical distribution in North America, McKesson Corporation has a vital market presence, emphasizing its importance in shaping healthcare logistics and innovation. Its efforts contribute to advancing healthcare delivery and responding to the evolving demands of the medical industry.
Never miss another MCK filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.